Indication
Migraine prevention
Migraine prevention refers to prophylactic therapy indicated for individuals with migraine, a chronic neurovascular disorder of the central nervous system characterized by recurrent, moderate-to-severe throbbing headache attacks frequently accompanied by nausea, photophobia, phonophobia, or focal neurological auras. Read more about Migraine prevention
169 drugs 97 manufacturers
Drugs that treat it
Common Migraine prevention therapies.
PROPRANOLOL HCL
PROPRANOLOL HCL
PROPRANOLOL HCL ER (propranolol HCl)
TOPIRAMATE
DIVALPROEX SODIUM
DIVALPROEX SODIUM ER (divalproex sodium)
PROPRANOLOL HCL
PROPRANOLOL HCL ER (propranolol HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMigraine prevention refers to prophylactic therapy indicated for individuals with migraine, a chronic neurovascular disorder of the central nervous system characterized by recurrent, moderate-to-severe throbbing headache attacks frequently accompanied by nausea, photophobia, phonophobia, or focal neurological auras.
Prophylaxis is clinically indicated for both episodic and chronic migraine to decrease attack frequency, duration, and severity, particularly in patients experiencing frequent monthly headache days, profound functional disability, or intolerance or inadequate response to acute abortive therapies.
Pathophysiologically, preventive interventions target trigeminovascular system hyperexcitability, cortical spreading depression, central sensitization, and the release of inflammatory neuropeptides such as calcitonin gene-related peptide to suppress recurrent neurogenic neuroinflammation.
- nih.gov
Migraine prevention refers to prophylactic therapy indicated for individuals with migraine, a chronic neurovascular disorder of the central nervous system characterized by recurrent, moderate-to-severe throbbing headache attacks frequently accompanied by nausea, photophobia, phonophobia, or focal neurological auras
- nih.gov
Migraine prevention refers to prophylactic therapy indicated for individuals with migraine, a chronic neurovascular disorder of the central nervous system characterized by recurrent, moderate-to-severe throbbing headache attacks frequently accompanied by nausea, photophobia, phonophobia, or focal neurological auras Prophylaxis is clinically indicated for both episodic and chronic migraine to decrease attack frequency, duration, and severity, particularly in patients experiencing frequent monthly...
- nih.gov
Prophylaxis is clinically indicated for both episodic and chronic migraine to decrease attack frequency, duration, and severity, particularly in patients experiencing frequent monthly headache days, profound functional disability, or intolerance or inadequate response to acute abortive therapies
- fda.gov
Prophylaxis is clinically indicated for both episodic and chronic migraine to decrease attack frequency, duration, and severity, particularly in patients experiencing frequent monthly headache days, profound functional disability, or intolerance or inadequate response to acute abortive therapies
- aafp.org
Pathophysiologically, preventive interventions target trigeminovascular system hyperexcitability, cortical spreading depression, central sensitization, and the release of inflammatory neuropeptides such as calcitonin gene-related peptide to suppress recurrent neurogenic neuroinflammation
Personalize your experience
Follow Migraine prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.